Table 12 Assay studies of Tezacaftor and Ivacaftor in mobile phase and human plasma
Name of the drug | Label claim (mg) | Mobile phase | Human plasma | ||||
|---|---|---|---|---|---|---|---|
Amount found (mg) | Assay % | % RSD | Amount found (mg) | Assay % | % RSD | ||
Tezacaftor | 30 | 30.275 | 101.01 | 1.172 | 30.41 | 101.35 | 0.625 |
Ivacaftor | 45 | 45.3 | 100.71 | 1.23 | 44.925 | 99.8 | 1.57 |